Costs associated with informal health care pathway for patients with suspected Lyme borreliosis

Coûts associés au parcours de soins informels pour les patients avec suspicion de la borréliose de Lyme

Lamriss Hamadou, Fantine Buteau, Delphine Martineau, Léo Sauvat, Martine Audibert () and Olivier Lesens
Additional contact information
Lamriss Hamadou: CERDI - Centre d'Études et de Recherches sur le Développement International - IRD - Institut de Recherche pour le Développement - CNRS - Centre National de la Recherche Scientifique - UCA - Université Clermont Auvergne, CHU Clermont-Ferrand
Fantine Buteau: CERDI - Centre d'Études et de Recherches sur le Développement International - IRD - Institut de Recherche pour le Développement - CNRS - Centre National de la Recherche Scientifique - UCA - Université Clermont Auvergne, CHU Clermont-Ferrand
Delphine Martineau: CHU Clermont-Ferrand
Léo Sauvat: CHU Clermont-Ferrand
Martine Audibert: CERDI - Centre d'Études et de Recherches sur le Développement International - UCA [2017-2020] - Université Clermont Auvergne [2017-2020] - CNRS - Centre National de la Recherche Scientifique, FERDI - Fondation pour les Etudes et Recherches sur le Développement International
Olivier Lesens: UMIT - Unité des Maladies Infectieuses et Tropicales - Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française], CHU Clermont-Ferrand

Post-Print from HAL

Abstract: Objectives: to compare the direct and indirect medical costs of patients with suspected Lyme borreliosis according to whether or not they had used an informal care pathway. Patients and methods: We retraced the care pathways of participating patients by a prospective questionnaire survey and a retrospective analysis of care records. Direct and indirect costs were estimated using a micro-costing method from different perspectives. We compared the costs of patients who had consulted a "Lyme Doctor" (informal care pathway) with those who had only used the formal care pathway. Non-parametric tests were used to test the significance of the differences between the two groups of patients. Results: Of 103 eligible patients, 49 (including 12 who used an informal health care pathway) agreed to be investigated. Five expenditures items supported entirely by patients were significantly higher for patients following an informal care pathway: productivity loss (3 041 ± 6 580 versus 194 ± 1 177 euros, p=0.01), alternative therapies (3 484 ± 7 308 versus 369 ± 956 euros), biological tests sent abroad (571 ± 1 415 versus 17 ± 92 euros, p

Keywords: Lyme borreliosis; Cost; Health care; Informal sector; Patient's perspective (search for similar items in EconPapers)
Date: 2024-03
References: Add references at CitEc
Citations:

Published in Infectious Diseases Now, 2024, 54 (2), pp.104841. ⟨10.1016/j.idnow.2023.104841⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-04464237

DOI: 10.1016/j.idnow.2023.104841

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().